Stuttgart - Delayed Quote EUR

AbCellera Biologics Inc (8QQ.SG)

1.7780
+0.0035
+(0.20%)
At close: May 9 at 9:32:58 PM GMT+2
Loading Chart for 8QQ.SG
  • Previous Close 1.7745
  • Open 1.7925
  • Bid 1.7780 x --
  • Ask 1.8045 x --
  • Day's Range 1.7780 - 1.7925
  • 52 Week Range 1.6505 - 3.7580
  • Volume 0
  • Avg. Volume 331
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8QQ.SG

View More

Performance Overview: 8QQ.SG

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8QQ.SG
35.90%
S&P 500 (^GSPC)
3.77%

1-Year Return

8QQ.SG
49.16%
S&P 500 (^GSPC)
8.55%

3-Year Return

8QQ.SG
71.77%
S&P 500 (^GSPC)
41.81%

5-Year Return

8QQ.SG
89.68%
S&P 500 (^GSPC)
93.18%

Compare To: 8QQ.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8QQ.SG

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    539.99M

  • Enterprise Value

    40.70M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    20.37

  • Price/Book (mrq)

    0.56

  • Enterprise Value/Revenue

    1.58

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8QQ.SG

View More

Company Insights: 8QQ.SG

Research Reports: 8QQ.SG

View More